Screener
Twist Bioscience Corporation TWST Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (In thousands, except per share data) | March 31,2026 | September 30,2025 |
|---|---|---|
| Investment in equity securities[1] | 68,087 | 54,337 |
| Goodwill | 82,195 | 82,195 |
| Intangible assets, net | 12,996 | 13,425 |
| Restricted cash, non-current | 2,182 | 2,376 |
| Other non-current assets[1] | 5,434 | 4,902 |
| Total assets | $676,214 | $641,861 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's restricted cash?
- Twist Bioscience Corporation (TWST) reported restricted cash of $2.18M in Q1 2026.
- How has Twist Bioscience Corporation's restricted cash changed year-over-year?
- Twist Bioscience Corporation's restricted cash decreased by 13.1% year-over-year, from $2.51M to $2.18M.
- What is the long-term trend for Twist Bioscience Corporation's restricted cash?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's restricted cash has grown at a 11.6% compound annual growth rate (CAGR), from $1.53M to $2.38M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Twist Bioscience Corporation's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude